Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Non-Current Deffered Revenue (2016 - 2020)

Historic Non-Current Deffered Revenue for Axogen (AXGN) over the last 8 years, with Q1 2020 value amounting to $12000.0.

  • Axogen's Non-Current Deffered Revenue fell 6470.59% to $12000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $12000.0, marking a year-over-year decrease of 6470.59%. This contributed to the annual value of $15000.0 for FY2019, which is 6428.57% down from last year.
  • Latest data reveals that Axogen reported Non-Current Deffered Revenue of $12000.0 as of Q1 2020, which was down 6470.59% from $15000.0 recorded in Q4 2019.
  • In the past 5 years, Axogen's Non-Current Deffered Revenue registered a high of $109332.0 during Q2 2017, and its lowest value of $12000.0 during Q1 2020.
  • Its 5-year average for Non-Current Deffered Revenue is $60805.8, with a median of $61985.0 in 2018.
  • As far as peak fluctuations go, Axogen's Non-Current Deffered Revenue soared by 3562.81% in 2017, and later plummeted by 6470.59% in 2020.
  • Quarter analysis of 5 years shows Axogen's Non-Current Deffered Revenue stood at $92215.0 in 2016, then decreased by 26.26% to $68000.0 in 2017, then crashed by 38.24% to $42000.0 in 2018, then plummeted by 64.29% to $15000.0 in 2019, then dropped by 20.0% to $12000.0 in 2020.
  • Its Non-Current Deffered Revenue stands at $12000.0 for Q1 2020, versus $15000.0 for Q4 2019 and $22000.0 for Q3 2019.